[go: up one dir, main page]

AU2002308169A1 - Compositions and methods for reducing rna virus pathogenicity - Google Patents

Compositions and methods for reducing rna virus pathogenicity

Info

Publication number
AU2002308169A1
AU2002308169A1 AU2002308169A AU2002308169A AU2002308169A1 AU 2002308169 A1 AU2002308169 A1 AU 2002308169A1 AU 2002308169 A AU2002308169 A AU 2002308169A AU 2002308169 A AU2002308169 A AU 2002308169A AU 2002308169 A1 AU2002308169 A1 AU 2002308169A1
Authority
AU
Australia
Prior art keywords
compositions
methods
rna virus
virus pathogenicity
reducing rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002308169A
Inventor
Melinda Beck
Bruce German
Orville Levander
Peter Van Dael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
University of North Carolina at Chapel Hill
Original Assignee
Societe des Produits Nestle SA
Nestle SA
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA, University of North Carolina at Chapel Hill filed Critical Societe des Produits Nestle SA
Publication of AU2002308169A1 publication Critical patent/AU2002308169A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002308169A 2001-03-28 2002-03-26 Compositions and methods for reducing rna virus pathogenicity Abandoned AU2002308169A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81938701A 2001-03-28 2001-03-28
US09/819,387 2001-03-28
PCT/EP2002/003025 WO2002078717A2 (en) 2001-03-28 2002-03-26 Compositions and methods for reducing rna virus pathogenicity

Publications (1)

Publication Number Publication Date
AU2002308169A1 true AU2002308169A1 (en) 2002-10-15

Family

ID=25228011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002308169A Abandoned AU2002308169A1 (en) 2001-03-28 2002-03-26 Compositions and methods for reducing rna virus pathogenicity

Country Status (2)

Country Link
AU (1) AU2002308169A1 (en)
WO (1) WO2002078717A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111568921A (en) * 2020-04-20 2020-08-25 奥格生物技术（六安）有限公司 Novel selenium preparation formula for promoting recovery of patients with coronavirus and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2089607C (en) * 1992-11-05 1997-11-04 Ranjit K. Chandra Nutritional supplement for the elderly
DE69841217D1 (en) * 1997-01-13 2009-11-19 Univ Emory GLUTATHION FOR THE TREATMENT OF INFLUENZA INFECTIONS
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement

Also Published As

Publication number Publication date
WO2002078717A3 (en) 2003-08-28
WO2002078717A2 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
EP1292603B8 (en) Methods and compositions for treating hepatitis c virus
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2003239129A1 (en) Methods and compositions for dna manipulation
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002346686A1 (en) Compositions and method for treating hepatitis virus infection
AU2003286486A1 (en) Methods and compositions for immunization against hiv
AU2001275155A1 (en) Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
AU2002306968A1 (en) Ogri gene disruptions, compositions and methods relating thereto
AU2003294757A1 (en) Formulations useful against hepatitis c virus infections
AU2002353780A1 (en) Mo54 gene disruptions, compositions and methods related thereto
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002365442A1 (en) Method of inhibiting pathogenicity of infectious agents
AU2002324753A1 (en) Composition and method for treating viral infection
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2002366809A1 (en) Syn3 compositions and methods
AU2002316512A1 (en) Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU2001234616A1 (en) Vaccine composition, process and methods
AU2003275069A1 (en) Compositions and methods for preventing infection
AU2003303948A1 (en) Compositions and methods for preventing infection
AU2002308169A1 (en) Compositions and methods for reducing rna virus pathogenicity
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2002350181A1 (en) Compositions and methods for viral delivery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase